| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121413 | Journal of Clinical Virology | 2012 | 8 Pages |
Abstract
Our study found a high prevalence of drug resistance and supports the need for appropriate laboratory monitoring in clinical practice and access to drug options in case of virological failure.
Keywords
DRVIQRDDITPV3TCDLVATVAZTd4TSQVABCEFVEmtricitabineLPVFPVNNRTINRTIFTCIDVMDRTipranavirEtravirineIndinavirIPKNFVunique recombinant formTDFURFETRFCRCRFNVPEfavirenzAbacavirAtazanavirStavudineTenofovirSusceptibleDarunavirAntiretroviral therapyDelavirdinedidanosineRitonavirZidovudineSaquinavirconfidence intervalcirculating recombinant formfosamprenavirLamivudineLopinavirinterquartile rangeResistanceMultidrug resistancenucleoside reverse transcriptase inhibitorProtease inhibitorodds ratioNelfinavirNevirapineARThuman immunodeficiency virusHIVCuba
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Vivian KourÃ, Yoan Alemán, Lissette Pérez, Jorge Pérez, Carlos Fonseca, Consuelo Correa, Carlos Aragonés, Jorge Campos, Delmis Álvarez, Yoeri Schrooten, Nathalie Dekeersmaeker, Stijn Imbrechts, Gertjan Beheydt, Lore Vinken, Daniel Pérez,